mRNA production are developmentally normal. Mol Neurobiol
8:121–127.
Masu Y, Wolf E, Holtmann B, Sendtner M, Brem G, Thoenen H (1993)
Disruption of the CNTF gene results in motor neuron degeneration.
Nature 365:27–32.
McLennan NF, Brennan PM, McNeill A, Davies I, Fotheringham A,
Rennison KA, Ritchie D, Brannan F, Head MW, Ironside JW,
Williams A, Bell JE (2004) Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol 165:227–235.
McLennan NF, Rennison KA, Bell JE, Ironside JW (2001) In situ
hybridization analysis of PrP mRNA in human CNS tissues. Neuropathol Appl Neurobiol 27:373–383.
Moran LB, Graeber MB (2004) The facial nerve axotomy model. Brain
Res Brain Res Rev 44:154 –178.
Moran LB, Kosel S, Spitzer C, Schwaiger FW, Riess O, Kreutzberg
GW, Graeber MB (2001) Expression of alpha-synuclein in nonapoptotic, slowly degenerating facial motoneurones. J Neurocytol
30:515–521.
Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O (2000) Signal transduction
through prion protein. Science 289:1925–1928.
Nishida N, Tremblay P, Sugimoto T, Shigematsu K, Shirabe S, Petromilli C, Erpel SP, Nakaoke R, Atarashi R, Houtani T, Torchia M,
Sakaguchi S, DeArmond SJ, Prusiner SB, Katamine S (1999) A
mouse prion protein transgene rescues mice deficient for the prion
protein gene from Purkinje cell degeneration and demyelination.
Lab Invest 79:689 – 697.
Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95:13363–
13383.
Roucou X, Gains M, LeBlanc AC (2004) Neuroprotective functions of
prion protein. J Neurosci Res 75:153–161.
Roucou X, Giannopoulos PN, Zhang Y, Jodoin J, Goodyer CG, LeBlanc A (2005) Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma
MCF-7 cells. Cell Death Differ 12:783–795.
Roucou X, Guo Q, Zhang Y, Goodyer CG, LeBlanc AC (2003) Cytosolic prion protein is not toxic and protects against Bax-mediated
cell death in human primary neurons. J Biol Chem 278:40877–
40881.
Roucou X, LeBlanc AC (2005) Cellular prion protein neuroprotective
function: implications in prion diseases. J Mol Med 83:3–11.
Sakurai-Yamashita Y, Sakaguchi S, Yoshikawa D, Okimura N, Ma- suda Y, Katamine S, Niwa M (2005) Female-specific neuroprotection against transient brain ischemia observed in mice devoid of
prion protein is abolished by ectopic expression of prion proteinlike protein. Neuroscience 136:281–287.
Sales N, Rodolfo K, Hassig R, Faucheux B, Di Giamberardino L, Moya
KL (1998) Cellular prion protein localization in rodent and primate
brain. Eur J Neurosci 10:2464 –2471.
Sendtner M, Gotz R, Holtmann B, Escary JL, Masu Y, Carroll P, Wolf
E, Brem G, Brulet P, Thoenen H (1996) Cryptic physiological
trophic support of motoneurons by LIF revealed by double gene
targeting of CNTF and LIF. Curr Biol 6:686 – 694.
Shmerling D, Hegyi I, Fischer M, Blattler T, Brandner S, Gotz J,
Rulicke T, Flechsig E, Cozzio A, von Mering C, Hangartner C,
Aguzzi A, Weissmann C (1998) Expression of amino-terminally
truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93:203–214.
Shyu WC, Lin SZ, Chiang MF, Ding DC, Li KW, Chen SF, Yang HI, Li
H (2005) Overexpression of PrPC by adenovirus-mediated gene
targeting reduces ischemic injury in a stroke rat model. J Neurosci
25:8967– 8977.
Spudich A, Frigg R, Kilic E, Kilic U, Oesch B, Raeber A, Bassetti CL,
Hermann DM (2005) Aggravation of ischemic brain injury by prion
protein deficiency: role of ERK-1/-2 and STAT-1. Neurobiol Dis
20:442– 449.
Vanderluit JL, McPhail LT, Fernandes KJ, McBride CB, Huguenot C, Roy
S, Robertson GS, Nicholson DW, Tetzlaff W (2000) Caspase-3 is
